<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00576082</url>
  </required_header>
  <id_info>
    <org_study_id>3977</org_study_id>
    <nct_id>NCT00576082</nct_id>
  </id_info>
  <brief_title>Borrelia Species in Cutaneous Lyme Borreliosis</brief_title>
  <official_title>DIVERSITY OF BORRELIA SPECIES INVOLVED IN CUTANEOUS MANIFESTATIONS OF LYME BORRELIOSIS IN FRANCE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Société de Dermatologie Française</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to identify the species of Borrelia involved in the dermatologic
      manifestations of Lyme borreliosis in France. Indeed, in Europe, as opposed to North America,
      many bacterial species are involved in Lyme borreliosis. Yet, very few is known about the
      prevalence and distribution of different bacteriological species that account for the disease
      in France. Thus, this a nation-wide study in which all French dermatologists are invited to
      participate. Every adult patient presenting with one of the cutaneous manifestation of Lyme
      borreliosis: erythema migrans, lymphocytoma or acrodermatitis chronica atrophicans can be
      included in the study. If the patient agrees participating, after information and written
      consent, a cutaneous biopsy will be performed in order to isolate Borrelia by means of
      culture and PCR. An estimated 400 biopsies should be performed within 2 years.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 2008</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">900</enrollment>
  <condition>Lyme Borreliosis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cutaneous biopsy</intervention_name>
    <description>Cutaneous biopsy in order to search Borrelia by means of culture and PCR in this tissue sample</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Cutaneous biopsy specimen
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Every adult patient presenting with either erythema migrans, borrelial lymphocytoma or
        acrodermatitis chronica atrophicans
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Informed adult patient who signed written consent with one the following conditions:

          -  erythema migrans

          -  borrelial lymphocytoma

          -  acrodermatitis chronica atrophicans

        Exclusion criteria:

          -  pregnancy or lactation

          -  allergy to local anesthesia

          -  patient who refuses biopsy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan LISPKER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dan LIPSKER, MD</last_name>
    <phone>33.3.88.11.61.79</phone>
    <email>dan.lipsker@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Service de Dermatologie, Hôpital Civil</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan LIPSKER, MD</last_name>
      <phone>33.3.88.11.61.79</phone>
      <email>dan.lipsker@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Benoît JAULHAC, MD</last_name>
      <phone>33.3.90.24.37.80</phone>
      <email>benoit.jaulhac@medecine.u-strasbg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Dan LIPSKER, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benoît JAULHAC, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bernard CRIBIER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carine KIEFFER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eric FROUIN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pauline LEMORDANT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile PERRIGOUARD, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Nicolas SCRIVENER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Virginie LUTZ, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service des Maladies infectieuses et tropicales, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yves HANSMANN, MD</last_name>
      <phone>33.3.69.55.09.78</phone>
      <email>yves.hansmann@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Yves HANSMANN, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Guillaume CAMUSET, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2007</study_first_submitted>
  <study_first_submitted_qc>December 17, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 18, 2007</study_first_posted>
  <last_update_submitted>March 21, 2018</last_update_submitted>
  <last_update_submitted_qc>March 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 22, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lyme borreliosis</keyword>
  <keyword>Erythema migrans</keyword>
  <keyword>Borrelial lymphocytoma</keyword>
  <keyword>Acrodermatitis chronica atrophicans</keyword>
  <keyword>Borrelia burgdorferi</keyword>
  <keyword>Borrelia afzelii</keyword>
  <keyword>Borrelia garinii</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Borrelia Infections</mesh_term>
    <mesh_term>Lyme Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

